U.S. Government to Grant Exclusive License for Ungulate Vaccination Patents to University of Maryland

Summary

The U.S. government has announced its intention to grant an exclusive, revocable license to the University of Maryland for the use of certain patents related to a vaccine against Gram-negative bacterial infections in ungulates, as outlined in U.S. Patent Nos. 7,235,644, 7,025,963, and 7,018,636.